» Authors » Alexander Navarini

Alexander Navarini

Explore the profile of Alexander Navarini including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 61
Citations 844
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Goessinger E, Niederfeilner J, Cerminara S, Maul J, Kostner L, Kunz M, et al.
J Eur Acad Dermatol Venereol . 2024 Feb; 38(12):2240-2249. PMID: 38411348
Background: Artificial intelligence (AI) shows promising potential to enhance human decision-making as synergistic augmented intelligence (AuI), but requires critical evaluation for skin cancer screening in a real-world setting. Objectives: To...
12.
Kliesener T, Jandek M, Navarini A, Brandt O, Muller S
BMC Med Educ . 2024 Feb; 24(1):116. PMID: 38321407
Background: Dermatology teaching is fundamental for the promotion of young colleagues in our specialty. However, traditional teaching methods are being scrutinized by students of the 'Generation Y and Z', which...
13.
Merkel T, Navarini A, Mueller S
Photodermatol Photoimmunol Photomed . 2024 Jan; 40(1):e12948. PMID: 38288769
Background: Phototherapy is a mainstay to treat itchy conditions. However, only little is known about differences in the antipruritic effect of phototherapy amongst different skin conditions, phototypes and genders. Methods:...
14.
Lapides R, Saravi B, Mueller A, Wang-Evers M, Maul L, Nemeth I, et al.
Cancers (Basel) . 2023 Dec; 15(24). PMID: 38136411
The incidence of cutaneous melanoma continues to rise despite the increased use of sunscreens within the last several decades. Some research even suggests that the use of sunscreen is associated...
15.
Roider E, Lakatos A, McConnell A, Wang P, Mueller A, Kawakami A, et al.
bioRxiv . 2023 Nov; PMID: 38014031
One Sentence Summary: MITF promote melanoma survival via increasing ROS tolerance.
16.
Feuchter S, Bari O, Navarini A, Kunz M
Dermatol Surg . 2023 May; 49(8):791-793. PMID: 37134241
No abstract available.
17.
Huber S, Navarini A, Brandt O, Muller S
J Dtsch Dermatol Ges . 2023 Mar; 21(3):239-244. PMID: 36929556
No abstract available.
18.
Huang K, Wu X, Li Y, Lv C, Yan Y, Wu Z, et al.
J Med Internet Res . 2023 Mar; 25:e44932. PMID: 36927843
Background: Psoriasis is one of the most frequent inflammatory skin conditions and could be treated via tele-dermatology, provided that the current lack of reliable tools for objective severity assessments is...
19.
Huber S, Navarini A, Brandt O, Muller S
J Dtsch Dermatol Ges . 2023 Mar; 21(3):239-243. PMID: 36892188
Colchicine, which was already used by the ancient Egyptians, has recently experienced a renaissance in various medical disciplines, including dermatology. However, due to the potentially significant side effects of systemic...
20.
Augustin M, Sommer R, Dauden E, Laws P, de Jong E, Fabbrocini G, et al.
BMJ Open . 2023 Feb; 13(2):e060536. PMID: 36792337
Introduction: Psoriasis is a chronic inflammatory skin disease that negatively impacts the quality of life of patients and their families. However, the most commonly used decision-making tools in psoriasis, Psoriasis...